0000950170-24-027326.txt : 20240306 0000950170-24-027326.hdr.sgml : 20240306 20240306171534 ACCESSION NUMBER: 0000950170-24-027326 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240304 FILED AS OF DATE: 20240306 DATE AS OF CHANGE: 20240306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LENO SAM R CENTRAL INDEX KEY: 0001238660 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36569 FILM NUMBER: 24727021 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lantheus Holdings, Inc. CENTRAL INDEX KEY: 0001521036 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 352318913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 BUSINESS PHONE: 978 671-8001 MAIL ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 FORMER COMPANY: FORMER CONFORMED NAME: Lantheus MI Holdings, Inc. DATE OF NAME CHANGE: 20110517 4 1 ownership.xml 4 X0508 4 2024-03-04 0001521036 Lantheus Holdings, Inc. LNTH 0001238660 LENO SAM R C/O LANTHEUS HOLDINGS, INC. 201 BURLINGTON ROAD, SOUTH BLDG BEDFORD MA 01730 true false false false false Common Stock 2024-03-04 4 M false 2045 16.30 A 59982 D Common Stock 2024-03-04 4 M false 7943 12.59 A 67925 D Common Stock 2024-03-04 4 M false 8333 6.00 A 76258 D Common Stock 2024-03-04 4 M false 4068 64.20 A 80326 D Common Stock 2024-03-04 4 S false 5025 64.81 D 75301 D Common Stock 2024-03-04 4 S false 17364 65.60 D 57937 D Stock Option (right to buy) 16.30 2024-03-04 4 M false 2045 0.00 D 2024-05-16 Common Stock 2045 0 D Stock Option (right to buy) 12.59 2024-03-04 4 M false 7943 0.00 D 2025-05-16 Common Stock 7943 0 D Stock Option (right to buy) 6.00 2024-03-04 4 M false 8333 0.00 D 2025-06-25 Common Stock 8333 0 D Stock Option (right to buy) 64.20 2024-03-04 4 M false 4068 0.00 D 2023-05-06 2032-05-06 Common Stock 4068 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.21 to $65.19, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.21 to $66.14, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. The stock options under this grant vested in equal monthly installments over the twelve months beginning on June 16, 2014. The stock options under this grant vested in equal monthly installments over the twelve months beginning on June 16, 2015. The stock options under this grant vested in equal annual installments over the three-year period beginning on June 25, 2016. /s/ Eric M. Green, attorney-in-fact 2024-03-06